Skip to content

Public FDA record

Z-1312-2021: Coronavirus antigen detection test system - Product Usage: intended for the qualitative detection of the

Recall record Z-1312-2021 for LumiraDx. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1312-2021
Company in FDA record
LumiraDx
FDA record creation date
Mar 26, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Two lots of test strips failed QC testing using blank buffer due to false positives.

Source facts

Action
On 2/23/2020, LumiraDx issued an Urgent Device Medical Corrective Field Action notice to customers, advising them of a mandatory field corrective action in the form of a software update for the LumiraDx SARS-CoV-2 Antigen (Ag) Test.
Initiated
2021-02-03
Root cause
Process design
Terminated
2022-07-13
Distribution
US nationwide distribution.
Recall number
Z-1312-2021
Recall status
Terminated
CDRH record ID
185885
FDA record created
2021-03-26
Recall event number
87366

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗